Go Pro
→ If you keep cash in a U.S. bank account… read this NOW (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DraftKings Inc. stock logo
DKNG
DraftKings
$18.59
-3.9%		$23.57
$18.52
▼
$36.98
$9.23B1.6113.57 million shs17.83 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$190.01
+0.6%		$122.75
$22.28
▼
$208.90
$75.86B1.0911.94 million shs10.27 million shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DraftKings Inc. stock logo
DKNG
DraftKings
+1.84%-9.03%-17.45%-25.26%-44.97%
Moderna, Inc. stock logo
MRNA
Moderna
-1.89%-3.02%+22.47%+136.89%+584.57%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DraftKings Inc. stock logo
DKNG
DraftKings
$18.59
-3.9%		$23.57
$18.52
▼
$36.98
$9.23B1.6113.57 million shs17.83 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$190.01
+0.6%		$122.75
$22.28
▼
$208.90
$75.86B1.0911.94 million shs10.27 million shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DraftKings Inc. stock logo
DKNG
DraftKings
+1.84%-9.03%-17.45%-25.26%-44.97%
Moderna, Inc. stock logo
MRNA
Moderna
-1.89%-3.02%+22.47%+136.89%+584.57%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DraftKings Inc. stock logo
DKNG
DraftKings
2.73
Moderate Buy$34.1483.63% Upside
Moderna, Inc. stock logo
MRNA
Moderna
2.08
Hold$77.83-59.04% Downside

Current Analyst Ratings Breakdown

Latest MRNA and DKNG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/1/2026
DraftKings Inc. stock logo
DKNG
DraftKings
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$30.00 ➝ $25.00
9/30/2026
Moderna, Inc. stock logo
MRNA
Moderna
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeNeutral ➝ Sell$60.00 ➝ $80.00
9/28/2026
DraftKings Inc. stock logo
DKNG
DraftKings
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform
9/25/2026
Moderna, Inc. stock logo
MRNA
Moderna
Sanford C. Bernstein logo
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Perform
9/24/2026
DraftKings Inc. stock logo
DKNG
DraftKings
Citizens Jmp logo
Citizens Jmp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetMarket Outperform$37.00 ➝ $35.00
9/23/2026
Moderna, Inc. stock logo
MRNA
Moderna
Singular Research logo
Singular Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
9/22/2026
Moderna, Inc. stock logo
MRNA
Moderna
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
9/18/2026
DraftKings Inc. stock logo
DKNG
DraftKings
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$49.00 ➝ $48.00
9/18/2026
DraftKings Inc. stock logo
DKNG
DraftKings
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$35.00
9/9/2026
Moderna, Inc. stock logo
MRNA
Moderna
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/8/2026
DraftKings Inc. stock logo
DKNG
DraftKings
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform
(Data available from 10/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DraftKings Inc. stock logo
DKNG
DraftKings
$6.05B1.52$0.73 per share25.61$1.27 per share14.64
Moderna, Inc. stock logo
MRNA
Moderna
$1.94B39.02N/AN/A$22.14 per share8.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DraftKings Inc. stock logo
DKNG
DraftKings
$3.71M-$0.38N/A15.361.92-2.68%-11.26%-1.61%11/5/2026 (Estimated)
Moderna, Inc. stock logo
MRNA
Moderna
-$2.82B-$7.99N/AN/AN/A-141.43%-28.30%-19.39%11/5/2026 (Estimated)

Latest MRNA and DKNG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2026Q2 2026
DraftKings Inc. stock logo
DKNG
DraftKings
$0.0218$0.09+$0.0682-$0.14$1.51 billion$1.44 billion
7/31/2026Q2 2026
Moderna, Inc. stock logo
MRNA
Moderna
-$2.03-$1.97+$0.06-$1.97$102.93 million$145.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DraftKings Inc. stock logo
DKNG
DraftKings
N/AN/AN/AN/AN/A
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DraftKings Inc. stock logo
DKNG
DraftKings
3.22
1.02
1.02
Moderna, Inc. stock logo
MRNA
Moderna
0.09
2.29
2.18

Institutional Ownership

CompanyInstitutional Ownership
DraftKings Inc. stock logo
DKNG
DraftKings
37.70%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%

Insider Ownership

CompanyInsider Ownership
DraftKings Inc. stock logo
DKNG
DraftKings
47.18%
Moderna, Inc. stock logo
MRNA
Moderna
10.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
DraftKings Inc. stock logo
DKNG
DraftKings
5,500496.45 million262.23 millionOptionable
Moderna, Inc. stock logo
MRNA
Moderna
4,700399.24 million356.12 millionOptionable

Recent News About These Companies

Healthcare Stocks To Keep An Eye On - October 2nd
October 2 at 1:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-healthcare-stocks-to-keep-an-eye-on-october-2nd-2026-10-02/
Moderna (MRNA) Stock Rallies on Nasdaq-100 Inclusion News
October 2 at 12:44 PM  |  coincentral.comC
Biotech Stocks To Watch Now - October 2nd
October 2 at 12:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-biotech-stocks-to-watch-now-october-2nd-2026-10-02/
SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot
October 2 at 7:43 AM  |  stocktwits.comS
Why Is Moderna, Inc. (NASDAQ: MRNA) Stock Up 569% This Year?
October 2 at 6:34 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31078286
Moderna stock rises 2% on Nasdaq 100 entry but this analyst says sell
October 2 at 6:09 AM  |  invezz.comI
Moderna loses US government license defense in Northwestern patent case
October 2 at 1:27 AM  |  reuters.comhttps://www.reuters.com/legal/government/moderna-loses-us-government-license-defense-northwestern-patent-case-2026-10-01/
Moderna slips as Citi cuts to Sell on “unjustifiable” valuation
October 2 at 1:27 AM  |  seekingalpha.comhttps://seekingalpha.com/news/4648418-moderna-stock-slips-citi-cuts-sell
Moderna (MRNA) Stock Dips While Market Gains: Key Facts
October 1 at 8:27 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/moderna-mrna-stock-dips-while-205005439.html
Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026
October 1 at 8:27 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/moderna-inc-join-nasdaq-100-000000029.html
Moderna to replace Warner Bros Discovery  on Nasdaq 100
October 1 at 8:12 PM  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/moderna-join-nasdaq-100-replacing-warner-bros-discovery-2026-10-02/
Moderna (MRNA) Stock Dips While Market Gains: Key Facts
October 1 at 6:50 PM  |  zacks.comhttps://www.zacks.com/stock/news/2999206/moderna-mrna-stock-dips-while-market-gains-key-facts?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_6v1-2999206
After Moderna's 'Outsized Run,' It May Be Time For This Bearish Move
October 1 at 3:26 PM  |  msn.comhttps://www.msn.com/en-us/news/other/after-modernas-outsized-run-it-may-be-time-for-this-bearish-move/ar-AA2dmyvv
Top Healthcare Stocks To Watch Today - October 1st
October 1 at 1:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-top-healthcare-stocks-to-watch-today-october-1st-2026-10-01/
Biotech Stocks To Watch Now - October 1st
October 1 at 12:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-biotech-stocks-to-watch-now-october-1st-2026-10-01/
Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water
October 1 at 11:00 AM  |  247wallst.comhttps://247wallst.com/investing/2026/10/01/moderna-climbs-3-despite-citigroups-downgrade-to-sell-biontech-inches-higher-pfizer-treads-water/?utm_source=snapi
Citi delivers major verdict after Moderna’s remarkable 703% run
October 1 at 10:16 AM  |  thestreet.comhttps://www.thestreet.com/investing/stocks/mrna-mordena-stock-citi-downgrades-to-sell-raises-price-target-after-703-run
Is A Cancer Vaccine Coming? Moderna, Merck Boosted By The Buzz
October 1 at 10:16 AM  |  finance.yahoo.comhttps://finance.yahoo.com/m/fdcf8835-313e-3fae-93cc-4997a4b9dc95/is-a-cancer-vaccine-coming%3F.html
Critical Contrast: Moderna (NASDAQ:MRNA) & BioStem Technologies (OTCMKTS:BSEM)
October 1 at 6:31 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31073795
This Analyst Just Downgraded Moderna Stock. Here's Why.
September 30 at 11:45 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/analyst-just-downgraded-moderna-stock-204057714.html
Moderna Stock Slumps as Citi Says It's Time to Sell After 500% Rally This Year
September 30 at 4:06 PM  |  investopedia.comhttps://www.investopedia.com/market-update-moderna-stock-slumps-as-citi-says-its-time-to-sell-after-500-rally-this-year-mrna-12149780

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Micron, Coherent and Tower Semiconductor: 3 Stocks Built on AI's Bottlenecks
NVIDIA Just Named AI's Next Bottleneck—And These 3 Stocks Sit Right In It
By Bridget Bennett | September 20, 2026
Data center hallway with rows of server racks and cables, plus a monitoring room with computer screens in the background.
AI Token Costs Are Changing the Hardware vs. Software Debate
By Jeffrey Neal Johnson | September 6, 2026
A Tesla concept vehicle with illuminated front light bar drives on a road against a city skyline at dusk.
Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
By Sam Quirke | September 8, 2026
Scientist handles blood sample in lab, symbolizing early cancer detection.
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
By Bridget Bennett | September 6, 2026
DraftKings logo with a football, helmet, and poker chips displayed in a stadium setting.
DraftKings Falls 7.6%: Is Kalshi's NFL Lead Really That Big?
By Chris Markoch | September 24, 2026
DraftKings stock logo

DraftKings NASDAQ:DKNG

$18.59 -0.76 (-3.93%)
Closing price 04:00 PM Eastern
Extended Trading
$18.61 +0.02 (+0.11%)
As of 07:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DraftKings Inc. operates as a digital sports entertainment and gaming company in the United States and internationally. It provides online sports betting and casino, daily fantasy sports, media, and other consumer products, as well as retails sportsbooks. The company also engages in the design and development of sports betting and casino gaming software for online and retail sportsbooks, and iGaming operators. In addition, it offers DraftKings marketplace, a digital collectibles ecosystem designed for mainstream accessibility that offers curated NFT drops and supports secondary-market transactions. The company is headquartered in Boston, Massachusetts.

Moderna stock logo

Moderna NASDAQ:MRNA

$190.01 +1.07 (+0.57%)
Closing price 04:00 PM Eastern
Extended Trading
$189.45 -0.56 (-0.29%)
As of 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas